Armata Pharmaceuticals (ARMP) Capital Expenditures Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 46.88% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 8.97% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 16.27% |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | -68.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -68.47% |
| Dec 31, 2025 | 28.35% |
| Sep 30, 2025 | -42.81% |
| Jun 30, 2025 | -49.19% |
| Mar 31, 2025 | -25.14% |
| Dec 31, 2024 | -32.72% |
| Sep 30, 2024 | -16.40% |
| Jun 30, 2024 | 91.01% |
| Mar 31, 2024 | -5.69% |
| Dec 31, 2023 | 87.17% |
| Sep 30, 2023 | 251.31% |
| Jun 30, 2023 | -6.66% |
| Mar 31, 2023 | 168.36% |
| Dec 31, 2022 | -187.11% |
| Sep 30, 2022 | 179.81% |
| Jun 30, 2022 | 108.13% |
| Mar 31, 2022 | 18.45% |
| Dec 31, 2021 | -16.46% |
| Sep 30, 2021 | 55.43% |
| Dec 31, 2020 | 172.94% |
| Sep 30, 2020 | 34.89% |
| Jun 30, 2020 | 414.89% |
| Mar 31, 2020 | 175.01% |
| Dec 31, 2019 | 17.33% |
| Sep 30, 2019 | -61.87% |
| Jun 30, 2019 | 0.27% |
| Mar 31, 2019 | 8.23% |
| Dec 31, 2018 | 98.49% |
| Sep 30, 2018 | 10.14% |
| Dec 31, 2017 | 53.26% |
| Sep 30, 2017 | -37.78% |
| Jun 30, 2017 | -86.60% |
| Mar 31, 2017 | -72.05% |
| Dec 31, 2016 | 37.51% |
| Sep 30, 2016 | -3.23% |
| Jun 30, 2016 | 24.36% |